Atlas Trials

Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic Impairment

Clinical trial NCT06674915 · COMPLETED

Trial details

NCT number
NCT06674915
Sponsor
Chengdu Suncadia Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Complement Mediated Primary or Secondary Glomerular Diseases
Start date
2024-11-26
Primary completion
2026-01-16
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.